[1]
K. O. Kalko, “ADMINISTRATION OF CORVITIN AS AN OFF-LABEL AGENT FOR PHARMACOLOGICAL CORRECTION OF METABOLIC SYNDROME”, PEP, vol. 75, no. 1, pp. 97-102, Mar. 2021.